| Drug Type Small molecule drug | 
| Synonyms WJ003 | 
| Target | 
| Action inhibitors | 
| Mechanism Aurora A inhibitors(Serine/threonine-protein kinase Aurora-A inhibitors) | 
| Therapeutic Areas | 
| Active Indication | 
| Inactive Indication- | 
| Originator Organization | 
| Inactive Organization- | 
| License Organization- | 
| Drug Highest PhasePhase 1 | 
| First Approval Date- | 
| Regulation- | 
| Indication | Highest Phase | Country/Location | Organization | Date | 
|---|---|---|---|---|
| Small Cell Lung Cancer | Phase 1 | China  | 30 Nov 2022 | |
| Small Cell Lung Cancer | Phase 1 | China  | 30 Nov 2022 | |
| Triple Negative Breast Cancer | Phase 1 | China  | 30 Nov 2022 | |
| Triple Negative Breast Cancer | Phase 1 | China  | 30 Nov 2022 | 





